Literature DB >> 2556261

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

K Münger1, B A Werness, N Dyson, W C Phelps, E Harlow, P M Howley.   

Abstract

The E7 proteins encoded by the human papillomaviruses (HPVs) associated with anogenital lesions share significant amino acid sequence homology. The E7 proteins of these different HPVs were assessed for their ability to form complexes with the retinoblastoma tumor suppressor gene product (p105-RB). Similar to the E7 protein of HPV-16, the E7 proteins of HPV-18, HBV-6b and HPV-11 were found to associate with p105-RB in vitro. The E7 proteins of HPV types associated with a high risk of malignant progression (HPV-16 and HPV-18) formed complexes with p105-RB with equal affinities. The E7 proteins encoded by HPV types 6b and 11, which are associated with clinical lesions with a lower risk for progression, bound to p105-RB with lower affinities. The E7 protein of the bovine papillomavirus type 1 (BPV-1), which does not share structural similarity in the amino terminal region with the HPV E7 proteins, was unable to form a detectable complex with p105-RB. The amino acid sequences of the HPV-16 E7 protein involved in complex formation with p105-RB in vitro have been mapped. Only a portion of the sequences that are conserved between the HPV E7 proteins and AdE1A were necessary for association with p105-RB. Furthermore, the HPV-16 E7-p105-RB complex was detected in an HPV-16-transformed human keratinocyte cell line.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556261      PMCID: PMC401588          DOI: 10.1002/j.1460-2075.1989.tb08594.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides.

Authors:  S P Yee; P E Branton
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

3.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  In vitro mutagenesis of a putative DNA binding domain of SV40 large-T.

Authors:  D Kalderon; A E Smith
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

5.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

6.  Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells.

Authors:  S Yasumoto; A L Burkhardt; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

7.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

Authors:  D Smotkin; F O Wettstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Identification of a second transforming region in bovine papillomavirus DNA.

Authors:  J T Schiller; W C Vass; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells.

Authors:  F McCormick; E Harlow
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

10.  Polyoma virus transforming protein associates with the product of the c-src cellular gene.

Authors:  S A Courtneidge; A E Smith
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

View more
  411 in total

1.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.

Authors:  S T Oh; S Kyo; L A Laimins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130.

Authors:  J E Sutcliffe; C A Cairns; A McLees; S J Allison; K Tosh; R J White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Detection of peptides, proteins, and drugs that selectively interact with protein targets.

Authors:  Ilya G Serebriiskii; Olga Mitina; Elena N Pugacheva; Elizaveta Benevolenskaya; Elena Kotova; Garabet G Toby; Vladimir Khazak; William G Kaelin; Jonathan Chernoff; Erica A Golemis
Journal:  Genome Res       Date:  2002-11       Impact factor: 9.043

8.  Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.

Authors:  G A Gulliver; R L Herber; A Liem; P F Lambert
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias.

Authors:  Y Fujinaga; K Okazawa; A Nishikawa; Y Yamakawa; M Fukushima; I Kato; K Fujinaga
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

10.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.